| 000 | 01430 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250515093616.0 | ||
| 264 | 0 | _c20080403 | |
| 008 | 200804s 0 0 eng d | ||
| 022 | _a1440-1746 | ||
| 024 | 7 |
_a10.1111/j.1440-1746.2007.05207.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTostmann, Alma | |
| 245 | 0 | 0 |
_aAntituberculosis drug-induced hepatotoxicity: concise up-to-date review. _h[electronic resource] |
| 260 |
_bJournal of gastroenterology and hepatology _cFeb 2008 |
||
| 300 |
_a192-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAntitubercular Agents _xadverse effects |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 |
_aIsoniazid _xadverse effects |
| 650 | 0 | 4 |
_aLiver Diseases _xpathology |
| 650 | 0 | 4 |
_aPyrazinamide _xadverse effects |
| 650 | 0 | 4 |
_aRifampin _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTuberculosis _xdrug therapy |
| 700 | 1 | _aBoeree, Martin J | |
| 700 | 1 | _aAarnoutse, Rob E | |
| 700 | 1 | _ade Lange, Wiel C M | |
| 700 | 1 | _avan der Ven, Andre J A M | |
| 700 | 1 | _aDekhuijzen, Richard | |
| 773 | 0 |
_tJournal of gastroenterology and hepatology _gvol. 23 _gno. 2 _gp. 192-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1440-1746.2007.05207.x _zAvailable from publisher's website |
| 999 |
_c17513311 _d17513311 |
||